141 related articles for article (PubMed ID: 17477938)
21. Blocking of CD27-CD70 pathway by anti-CD70 antibody ameliorates joint disease in murine collagen-induced arthritis.
Oflazoglu E; Boursalian TE; Zeng W; Edwards AC; Duniho S; McEarchern JA; Law CL; Gerber HP; Grewal IS
J Immunol; 2009 Sep; 183(6):3770-7. PubMed ID: 19710474
[TBL] [Abstract][Full Text] [Related]
22. Formation, distribution, and elimination of infliximab and anti-infliximab immune complexes in cynomolgus monkeys.
Rojas JR; Taylor RP; Cunningham MR; Rutkoski TJ; Vennarini J; Jang H; Graham MA; Geboes K; Rousselle SD; Wagner CL
J Pharmacol Exp Ther; 2005 May; 313(2):578-85. PubMed ID: 15647331
[TBL] [Abstract][Full Text] [Related]
23. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
[TBL] [Abstract][Full Text] [Related]
24. Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of humanized monoclonal anti-IL-13 antibodies with different IL-13 neutralization mechanisms.
Vugmeyster Y; Szklut P; Tchistiakova L; Abraham W; Kasaian M; Xu X
Int Immunopharmacol; 2008 Mar; 8(3):477-83. PubMed ID: 18279802
[TBL] [Abstract][Full Text] [Related]
25. A novel murine anti-human Fas mAb which mitigates lymphadenopathy without hepatotoxicity.
Ichikawa K; Yoshida-Kato H; Ohtsuki M; Ohsumi J; Yamaguchi J; Takahashi S; Tani Y; Watanabe M; Shiraishi A; Nishioka K; Yonehara S; Serizawa N
Int Immunol; 2000 Apr; 12(4):555-62. PubMed ID: 10744657
[TBL] [Abstract][Full Text] [Related]
26. Amelioration of collagen-induced arthritis by human recombinant soluble FcgammaRIIb.
Magnusson SE; Andrén M; Nilsson KE; Sondermann P; Jacob U; Kleinau S
Clin Immunol; 2008 May; 127(2):225-33. PubMed ID: 18346938
[TBL] [Abstract][Full Text] [Related]
27. Anti-rheumatoid arthritic effect of madecassoside on type II collagen-induced arthritis in mice.
Liu M; Dai Y; Yao X; Li Y; Luo Y; Xia Y; Gong Z
Int Immunopharmacol; 2008 Nov; 8(11):1561-6. PubMed ID: 18652917
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
29. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
[TBL] [Abstract][Full Text] [Related]
30. Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis.
Murakami Y; Akahoshi T; Aoki N; Toyomoto M; Miyasaka N; Kohsaka H
Arthritis Rheum; 2009 Jun; 60(6):1615-23. PubMed ID: 19479878
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and pharmacodynamics of a humanized monoclonal antibody to factor IX in cynomolgus monkeys.
Benincosa LJ; Chow FS; Tobia LP; Kwok DC; Davis CB; Jusko WJ
J Pharmacol Exp Ther; 2000 Feb; 292(2):810-6. PubMed ID: 10640322
[TBL] [Abstract][Full Text] [Related]
32. Arthritogenic antibodies specific for a major type II collagen triple-helical epitope bind and destabilize cartilage independent of inflammation.
Nandakumar KS; Bajtner E; Hill L; Böhm B; Rowley MJ; Burkhardt H; Holmdahl R
Arthritis Rheum; 2008 Jan; 58(1):184-96. PubMed ID: 18163493
[TBL] [Abstract][Full Text] [Related]
33. Targeting of murine radiolabeled monoclonal antibodies in the lymphatics.
Parker RJ; Keenan AM; Dower SK; Steller MA; Holton OD; Sieber SM; Weinstein JN
Cancer Res; 1987 Apr; 47(8):2073-6. PubMed ID: 3828997
[TBL] [Abstract][Full Text] [Related]
34. The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis.
Van Roy M; Ververken C; Beirnaert E; Hoefman S; Kolkman J; Vierboom M; Breedveld E; 't Hart B; Poelmans S; Bontinck L; Hemeryck A; Jacobs S; Baumeister J; Ulrichts H
Arthritis Res Ther; 2015 May; 17(1):135. PubMed ID: 25994180
[TBL] [Abstract][Full Text] [Related]
35. Genetic deletion of faim reveals its role in modulating c-FLIP expression during CD95-mediated apoptosis of lymphocytes and hepatocytes.
Huo J; Xu S; Guo K; Zeng Q; Lam KP
Cell Death Differ; 2009 Jul; 16(7):1062-70. PubMed ID: 19300454
[TBL] [Abstract][Full Text] [Related]
36. Antigen-dependent internalization is related to rapid elimination from plasma of humanized anti-HM1.24 monoclonal antibody.
Amano J; Masuyama N; Hirota Y; Tanaka Y; Igawa Y; Shiokawa R; Okutani T; Miyayama T; Nanami M; Ishigai M
Drug Metab Dispos; 2010 Dec; 38(12):2339-46. PubMed ID: 20823293
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of a new human monoclonal antibody against cytomegalovirus. Third communication: correspondence of the idiotype activity and virus neutralization activity of the new monoclonal antibody, regavirumab in rat serum and its pharmacokinetics in rats and monkeys.
Arizono H; Sugano T; Kaida S; Shibusawa K; Karasawa Y; Esumi Y; Kondo S; Kiyoki M
Arzneimittelforschung; 1994 Jul; 44(7):909-13. PubMed ID: 7945531
[TBL] [Abstract][Full Text] [Related]
38. Toll-like receptor homolog RP105 modulates the antigen-presenting cell function and regulates the development of collagen-induced arthritis.
Tada Y; Koarada S; Morito F; Mitamura M; Inoue H; Suematsu R; Ohta A; Miyake K; Nagasawa K
Arthritis Res Ther; 2008; 10(5):R121. PubMed ID: 18847495
[TBL] [Abstract][Full Text] [Related]
39. No mixing of granulocytes and other lymphocytes in the inflamed joints of parabiosis mice with collagen-induced arthritis: possible in situ generation.
Nishizawa T; Kawamura T; Izumi N; Kawamura H; Fujii K; Abo T
Immunology; 2005 Jan; 114(1):133-8. PubMed ID: 15606803
[TBL] [Abstract][Full Text] [Related]
40. Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease.
Tabrizi M; Bornstein GG; Suria H
AAPS J; 2010 Mar; 12(1):33-43. PubMed ID: 19924542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
